These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 914991)

  • 21. An evaluation in pigs of Nobi-Vac AR and an experimental atrophic rhinitis vaccine containing P multocida DNT-toxoid and B bronchiseptica.
    Kobisch M; Pennings A
    Vet Rec; 1989 Jan; 124(3):57-61. PubMed ID: 2919495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. aroA deleted Bordetella bronchiseptica inspiring robust mucosal immune response and provide full protection against intranasal challenge.
    Zhang Q; Hu R; Hu J; He H; Tang X; Jin M; Chen H; Wu B
    Res Vet Sci; 2013 Feb; 94(1):55-61. PubMed ID: 22892249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A field evaluation of Nobi-Vac atrophic rhinitis vaccine.
    de Jong MF; Bouwkamp FT; Oosterwoud RA
    Vet Q; 1987 Jan; 9(1):49-59. PubMed ID: 3564317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of immunization with a Bordetella bronchiseptica bacterin on weight gain in weaning pigs.
    Goodnow RA; Lehr CD; McLennan J
    Vet Med Small Anim Clin; 1978 Sep; 73(9):1187-8. PubMed ID: 252361
    [No Abstract]   [Full Text] [Related]  

  • 25. The aetiological significance of Bordetella bronchiseptica and Pasteurella multocida in atrophic rhinitis of swine.
    Pedersen KB; Barfod K
    Nord Vet Med; 1981 Dec; 33(12):513-22. PubMed ID: 7335484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of nasal culturing procedures for the control of atrophic rhinitis caused by Bordetella bronchiseptica in swine.
    Farrington DO; Switzer WP
    J Am Vet Med Assoc; 1977 Jan; 170(1):34-6. PubMed ID: 830627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of six different regimens for the control of atrophic rhinitis in swine.
    Pejsak Z; Hogg A; Wasińska B; Foreman K
    Zentralbl Veterinarmed B; 1990 Oct; 37(8):593-8. PubMed ID: 2220195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Virulence of Pasteurella multocida in atrophic rhinitis of gnotobiotic pigs infected with Bordetella bronchiseptica.
    Rutter JM
    Res Vet Sci; 1983 May; 34(3):287-95. PubMed ID: 6878879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental atrophic rhinitis in gnotobiotic pigs.
    Miniats OP; Johnson JA
    Can J Comp Med; 1980 Oct; 44(4):358-65. PubMed ID: 7448626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atrophic rhinitis: appraisal of infection pressure on gnotobiotic piglets infected with Bordetella bronchiseptica.
    Martineau GP; Broes A; Martineau-Doize B
    Can J Comp Med; 1982 Oct; 46(4):376-81. PubMed ID: 7172101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inoculation experiments with Bordetella bronchiseptica strains in SPF pigs.
    Tornoe N; Nielsen NC
    Nord Vet Med; 1976; 28(4-5):233-42. PubMed ID: 934809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bordetella bronchiseptica and toxigenic type D Pasteurella multocida as agents of severe atrophic rhinitis of swine.
    Rhodes MB; New CW; Baker PK; Hogg A; Underdahl NR
    Vet Microbiol; 1987 Feb; 13(2):179-87. PubMed ID: 3564360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of commercial vaccines for protecting guinea pigs against Bordetella bronchiseptica pneumonia.
    Matherne CM; Steffen EK; Wagner JE
    Lab Anim Sci; 1987 Apr; 37(2):191-4. PubMed ID: 3599889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunization of pigs against Bordetella bronchiseptica infection by parenteral vaccination.
    Harris DL; Switzer WP
    Am J Vet Res; 1972 Oct; 33(10):1975-84. PubMed ID: 4342331
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies on the etiology of infectious atrophic rhinitis of swine. IV. Agglutination test with formolized antigen for Bordetella bronchiseptica infection in pigs.
    Ogata M; Kodama Y; Koshimizu K
    Nihon Juigaku Zasshi; 1973 Apr; 35(2):149-55. PubMed ID: 4738925
    [No Abstract]   [Full Text] [Related]  

  • 36. Protective effect by cell-free antigen obtained from culture supernatant of phase I Bordetella bronchiseptica.
    Ohgitani T; Uchida C; Okabe T; Sasaki N
    J Vet Med Sci; 1992 Feb; 54(1):37-42. PubMed ID: 1532748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of vaccines for atrophic rhinitis--a comparison of three challenge models.
    Magyar T; King VL; Kovács F
    Vaccine; 2002 Mar; 20(13-14):1797-802. PubMed ID: 11906767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induced atrophic rhinitis in rats.
    Kimman TG; Kamp EM
    Am J Vet Res; 1986 Nov; 47(11):2426-30. PubMed ID: 3789506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Vaccination against rhinitis atrophicans].
    Wittkowski G; Horner M; Tenhumberg H
    Berl Munch Tierarztl Wochenschr; 1980 Jun; 93(11):214-8. PubMed ID: 7406835
    [No Abstract]   [Full Text] [Related]  

  • 40. Genetic control of immune response to pseudorabies and atrophic rhinitis vaccines: I. Heterosis, general combining ability and relationship to growth and backfat.
    Meeker DL; Rothschild MF; Christian LL; Warner CM; Hill HT
    J Anim Sci; 1987 Feb; 64(2):407-13. PubMed ID: 3558146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.